Imaging molecular signatures in oligodendroglioma

被引：5

作者：

Cairncross, JG

机构：

[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada

[2] Tom Baker Canc Clin, Calgary, AB T2N 2T9, Canada

来源：

CLINICAL CANCER RESEARCH | 2004年 / 10卷 / 21期

关键词：

D O I：

10.1158/1078-0432.CCR-04-2018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：7109 / 7111

页数：3

共 19 条

[1] Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas [J].

Bauman, GS ;

Ino, Y ;

Ueki, K ;

Zlatescu, MC ;

Fisher, BJ ;

Macdonald, DR ;

Stitt, L ;

Louis, DN ;

Cairncross, JG .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (03) :825-830

[2] Influence of unrecognized molecular heterogeneity on randomized clinical trials [J].

Betensky, RA ;

Louis, DN ;

Cairncross, JG .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2495-2499

[3] Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].

Cairncross, JG ;

Ueki, K ;

Zlatescu, MC ;

Lisle, DK ;

Finkelstein, DM ;

Hammond, RR ;

Silver, JS ;

Stark, PC ;

Macdonald, DR ;

Ino, Y ;

Ramsay, DA ;

Louis, DN .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479

[4] SUCCESSFUL CHEMOTHERAPY FOR RECURRENT MALIGNANT OLIGODENDROGLIOMA [J].

CAIRNCROSS, JG ;

MACDONALD, DR .

ANNALS OF NEUROLOGY, 1988, 23 (04) :360-364

[5]

CAIRNCROSS JG, 2004, P AN M AM SOC CLIN, V23, P107

[6] Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy [J].

Chinot, OL ;

Honore, S ;

Dufour, H ;

Barrie, M ;

Figarella-Branger, D ;

Muracciole, X ;

Braguer, D ;

Martin, PM ;

Grisoli, F .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) :2449-2455

[7] High and low grade oligodendrogliomas (ODG): correlation of amino-acid and glucose uptakes using PET and histological classifications [J].

Giammarile, F ;

Cinotti, LE ;

Jouvet, A ;

Ramackers, JM ;

Saint Pierre, G ;

Thiesse, P ;

Jouanneau, E ;

Guyotat, J ;

Pelissou-Guyotat, I ;

Setiey, A ;

Honnorat, J ;

Le Bars, D ;

Frappaz, D .

JOURNAL OF NEURO-ONCOLOGY, 2004, 68 (03) :263-274

[8] Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions [J].

Hoang-Xuan, K ;

Capelle, L ;

Kujas, M ;

Taillibert, S ;

Duffau, H ;

Lejeune, J ;

Polivka, M ;

Crinière, E ;

Marie, Y ;

Mokhtari, K ;

Carpentier, AF ;

Laigle, F ;

Simon, JM ;

Cornu, P ;

Broët, P ;

Sanson, M ;

Delattre, JY .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3133-3138

[9]

Ino Y, 2001, CLIN CANCER RES, V7, P839

[10] Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4: An interim analysis [J].

Karim, ABMF ;

Afra, D ;

Cornu, P ;

Bleehan, N ;

Schraub, S ;

De Witte, O ;

Darcel, F ;

Stenning, S ;

Pierart, M ;

Van Glabbeke, M .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02) :316-324

← 1 2 →